Shiv Nadar University Delhi-NCR Successfully Concluded 4th Edition of Genomics India Conference 2024
05.02.2024 - 13:32:02Shiv Nadar University Delhi-NCR Successfully Concluded 4th Edition of Genomics India Conference 2024. More than 500 renowned leaders in genomics from the US, UK, Europe, and Asia Pacific participated in the three-day conference
Business Wire IndiaShiv Nadar University, Delhi NCR, India’s youngest Institution of Eminence (IoE), successfully concluded its three-day Genomics India Conference 2024 (GIC2024), that aimed at highlighting the latest research, technologies, breakthroughs, challenges, and strategies in understanding the genomics. Dr. Rajesh Gokhale, Secretary of the Department of Biotechnology, Government of India graced the event as its Chief Guest.
More than 500 renowned leaders in genomics from the US, UK, Europe, and Asia Pacific participated in the three-day conference. The event featured an impressive lineup of speakers, including Nobel laureates, leading researchers, government officials, and regulatory experts. Notable highlights included the workshop on next-generation sequencing (NGS) analytics and Genome Informatics Programme, providing attendees with practical insights into crucial topics such as NGS data QC, alignment/assembly, annotation, variant calling, interpretation, and reporting.
Genomics is the emerging science of understanding the human genome. It deals with the analysis of gene and genome and determines how the DNA in every human being affects individuality, health and disease. While genetics helps to know how some disease conditions are inherited in families. Profound analysis of complex diseases like asthma, cancer, diabetes, heart disease etc are performed by genomics studies because a combination of genetic and environmental factors causes these problems than just an individual gene.
Dr Raja Mugasimangalam, CEO of Genotypic Technology said, "Shiv Nadar University, Delhi NCR not only have a highly knowledgeable faculty well-versed in the science of genomics, but also students with great interest in this field. Recognizing genomics as the future and an enabling technology, we are eager to inspire the younger generation to embrace this field."
During the inaugural event, Shikhar Malhotra, CEO & Vice Chairman of HCL Healthcare, said, “HCL Healthcare focuses on preventive healthcare, particularly for companies and corporates. The overarching vision revolves around harnessing genomics for predictive analysis and healthcare, aiming to deliver precision-based solutions that significantly enhance lives. The Genomics Conference is an exciting opportunity for us to explore the cutting-edge possibilities in this field and truly revolutionize predictive healthcare.”
Dr Sanjeev Galande, Dean of School of Natural Science at Shiv Nadar University, Delhi NCR said, “Some scientists are focused on extending lifespan, while another group strives to understand how to lead a healthy life during aging. In any case, predictive healthcare is the future of medicine, and genomics and epigenomics play a significant role, providing us the power to comprehend and project our health journey for the years ahead. At the Center of Excellence in Epigenetics at the University, we are precisely addressing such complex health related problems using epigenomics methods and disease models.”
About Shiv Nadar Foundation
Established in 1994, by Shiv Nadar, Founder, HCL - a US$13.1 billion leading global technology enterprise, the Foundation is committed to the creation of a more equitable, merit-based society by empowering individuals through transformational education and bridging the socio-economic divide. Over the last 29 years the Foundation, has directly touched the lives of over 36,000 alumni and students through its marquee institutions in literacy, K12 and higher education. Today, the Foundation has a community of over 100,000 constituents, which includes not only globally dispersed alumni and students but also faculty members, corporate executives, and extended families.
The Foundation has invested over US$1.2 billion in its seven landmark institutions and initiatives across education and art. Currently, close to 15,000 students and over 2,200 faculty are part of the Foundation along with more than 24,000-strong globally dispersed alumni community.
The Foundation's students have gone to study at some of the best institutions globally including the Ivy League in the US and top universities in other countries including Australia, Singapore, China and UK. Students are also working in major corporations, including Goldman Sachs, Dell, Microsoft, Google, ZS Associates, Bain & Co., Mckinsey & Company, Berkadia, Palo Alto, Tata consulting engineers, Optum, Adobe, Silicon Labs, etc and several others both in India and across other geographies. Faculty across the Foundation institutions are drawn from the best Indian and international universities, with a strong focus on research and innovation.
The Shiv Nadar Foundation pursues the philosophy of 'Creative Philanthropy'. It is a powerful model that envisages the creation of institutions that are built to last and continue to impact future generations. It is an approach that allows sustained institutionalised philanthropy for long-term, high-impact, socio-economic transformation.
More than 500 renowned leaders in genomics from the US, UK, Europe, and Asia Pacific participated in the three-day conference. The event featured an impressive lineup of speakers, including Nobel laureates, leading researchers, government officials, and regulatory experts. Notable highlights included the workshop on next-generation sequencing (NGS) analytics and Genome Informatics Programme, providing attendees with practical insights into crucial topics such as NGS data QC, alignment/assembly, annotation, variant calling, interpretation, and reporting.
Genomics is the emerging science of understanding the human genome. It deals with the analysis of gene and genome and determines how the DNA in every human being affects individuality, health and disease. While genetics helps to know how some disease conditions are inherited in families. Profound analysis of complex diseases like asthma, cancer, diabetes, heart disease etc are performed by genomics studies because a combination of genetic and environmental factors causes these problems than just an individual gene.
Dr Raja Mugasimangalam, CEO of Genotypic Technology said, "Shiv Nadar University, Delhi NCR not only have a highly knowledgeable faculty well-versed in the science of genomics, but also students with great interest in this field. Recognizing genomics as the future and an enabling technology, we are eager to inspire the younger generation to embrace this field."
During the inaugural event, Shikhar Malhotra, CEO & Vice Chairman of HCL Healthcare, said, “HCL Healthcare focuses on preventive healthcare, particularly for companies and corporates. The overarching vision revolves around harnessing genomics for predictive analysis and healthcare, aiming to deliver precision-based solutions that significantly enhance lives. The Genomics Conference is an exciting opportunity for us to explore the cutting-edge possibilities in this field and truly revolutionize predictive healthcare.”
Dr Sanjeev Galande, Dean of School of Natural Science at Shiv Nadar University, Delhi NCR said, “Some scientists are focused on extending lifespan, while another group strives to understand how to lead a healthy life during aging. In any case, predictive healthcare is the future of medicine, and genomics and epigenomics play a significant role, providing us the power to comprehend and project our health journey for the years ahead. At the Center of Excellence in Epigenetics at the University, we are precisely addressing such complex health related problems using epigenomics methods and disease models.”
About Shiv Nadar Foundation
Established in 1994, by Shiv Nadar, Founder, HCL - a US$13.1 billion leading global technology enterprise, the Foundation is committed to the creation of a more equitable, merit-based society by empowering individuals through transformational education and bridging the socio-economic divide. Over the last 29 years the Foundation, has directly touched the lives of over 36,000 alumni and students through its marquee institutions in literacy, K12 and higher education. Today, the Foundation has a community of over 100,000 constituents, which includes not only globally dispersed alumni and students but also faculty members, corporate executives, and extended families.
The Foundation has invested over US$1.2 billion in its seven landmark institutions and initiatives across education and art. Currently, close to 15,000 students and over 2,200 faculty are part of the Foundation along with more than 24,000-strong globally dispersed alumni community.
The Foundation's students have gone to study at some of the best institutions globally including the Ivy League in the US and top universities in other countries including Australia, Singapore, China and UK. Students are also working in major corporations, including Goldman Sachs, Dell, Microsoft, Google, ZS Associates, Bain & Co., Mckinsey & Company, Berkadia, Palo Alto, Tata consulting engineers, Optum, Adobe, Silicon Labs, etc and several others both in India and across other geographies. Faculty across the Foundation institutions are drawn from the best Indian and international universities, with a strong focus on research and innovation.
The Shiv Nadar Foundation pursues the philosophy of 'Creative Philanthropy'. It is a powerful model that envisages the creation of institutions that are built to last and continue to impact future generations. It is an approach that allows sustained institutionalised philanthropy for long-term, high-impact, socio-economic transformation.
